IRadimed Corporation (IRMD) NASDAQ
Currency In USD
AD
- General
- Statistics
- Historical Data
- Profile
- Financials
AD
Currency In USD
| Market Cap | 1.24B |
| Enterprise Value | 1.19B |
| P/E Ratio | 50.2 |
| PEG Ratio | 4.55 |
| Price/Sales Ratio | 13.45 |
| Price/Book Ratio | 11.42 |
| Enterprise/Revenue | 12.77 |
| Enterprise/EBITDA | 35.91 |
| Fiscal Year | December 31, 2025 |
| Most Recent Quarter | June 30, 2026 |
| Profit Margin | 0.27 |
| Operating Margin | 0.32 |
| Return On Assets | 0.2 |
| Return On Equity | 0.23 |
| Revenue | 83.81M |
| Revenue/Share | 6.75 |
| Gross Profit | 64.32M |
| EBITDA | 30.74M |
| Net Income | 22.48M |
| Diluted EPS | 1.75 |
| Total Cash | 59.08M |
| Total Cash/Share | 4.62 |
| Total Debt | 0 |
| Total Debt/Equity | 0 |
| Current Ratio | 9.46 |
| Book Value Per Share | 7.96 |
| 52-Week Change | 28.53 |
| 52-Week High | 107.9 |
| 52-Week Low | 66.78 |
| Moving Average 50 Days | 94.35 |
| Moving Average 200 Days | 93.49 |
| Average Volume | 134,840 |
| Shares Outstanding | 12.78M |
| % Held by Institutions | 59.96 |
| Trailing Annual Dividend Rate | 1.24 |
| Trailing Annual Dividend Yield | 1.36 |
| Payout Ratio | 0.69 |
| Last Split Factor | N/A |
| Last Split Date | N/A |